Futura Medical is developing a portfolio of innovative products for two large markets, sexual health and pain.
Description: Topical gel for erectile dysfunction
Status: Phase 3 clinical trial completed. EU regulatory dossier submitted. US Pre-submission meeting with FDA Q4 2020. Specialist corporate advisers appointed
Description: Topical diclofenac pain relief gel
Status: Further laboratory work complete. Awaiting scientific advisory meeting with MHRA.
Description: Topical cannabidiol formulation
Status: Joint venture coolaboration. Early development stage to explore a number of disease states including pain relief.